Related Experiment Video
Updated: Jul 15, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Acute Chest Pain Following Bravo Device Placement
Ruha Reddy1, Brian A Holliday1, Marna Greenberg1
1Department of Emergency and Hospital Medicine, Lehigh Valley Health Network/University of South Florida Morsani College of Medicine, Bethlehem, USA.
Abstract:
A Bravo device is a continuous pH monitor, produced by Medtronic (Minneapolis, MN), that is placed on the esophageal mucosa during endoscopy and can be used in the evaluation of gastroesophageal reflux disease (GERD). The device detaches by itself and passes with feces in approximately 7-10 days. Because of its brief presence in the body, the device is an unusual finding on imaging and could easily be mistaken for a more ominous foreign body. The Bravo device is typically well tolerated but can be a source of severe discomfort. Its presence is an important consideration in the differential of chest pain and a contraindication to MRI. Here, we discuss a case of a patient presenting to the emergency department (ED) with acute chest pain who underwent Bravo device placement several days prior.
Related Concept Videos
Angina III: Clinical Manifestations and Assessment
Angina V: Nursing Management
Cardiac Catheterization II: Right Heart Catheterization
Angina IV: Management
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Pneumothorax-II
Clinical Manifestations:

